StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Gilead Sciences (GILD) PT Lowered to $89 at RBC Capital
October 25, 2019 6:27 AM
RBC Capital analyst Brian Abrahams lowered the price target on Gilead Sciences (NASDAQ: GILD) to $89.00 (from $91.00) while maintaining ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS View
Analyst PT Change
Next Articles
Gilead Sciences (GILD), Glympse Bio Report Strategic Collaboration for Use of Biomarker Technology in NASH Clinical Development
October 28, 2019 8:05 AM
Gilead Sciences (GILD) PT Lowered to $81 at BMO Capital
October 25, 2019 5:20 AM
Options expected to have increasing volume: LEA GT ALGT COF GILD FSLR ILMN
October 25, 2019 4:35 AM
Gilead Sciences (GILD) Declares $0.63 Quarterly Dividend; 3.8% Yield
October 24, 2019 5:22 PM
Gilead Sciences (GILD) Tops Q3 EPS by 1c
October 24, 2019 4:03 PM
Gilead Sciences Announces Fourth Quarter 2019 Dividend
October 24, 2019 4:02 PM
